Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

Patricia holds her Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She also served as a PhD student research assistant in the Laboratory of Doctor David A. Fidock, Department of Microbiology & Immunology, Columbia University, New York.

February 26, 2015February 26, 2015

Hypertension Increases the Risk for Cardiac Disease in Rheumatoid Arthritis

News, rheumatoid arthritis

In a recent study entitled “The Impact of Traditional Cardiovascular Risk Factors on Cardiovascular Outcomes in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis,” researchers suggest that traditional cardiovascular ... Read more

February 11, 2015February 11, 2015

New Systematic Review Analyzes Effects of Exercise on Depression in Adults With Various Forms of Arthritis

News, rheumatoid arthritis

A recent study entitled “Effects of exercise on depression in adults with arthritis: a systematic review with meta-analysis of randomized controlled trials” suggests that exercise activity can improve depression symptoms ... Read more

January 26, 2015January 26, 2015

Arachidonic Acid Intake Not Linked to Rheumatoid Arthritis, Study on Animal Models Shows

News

In a new study entitled “Dietary supplementation with arachidonic acid increases arachidonic acid content in paw, but does not affect arthritis severity or prostaglandin E2 content in rat adjuvant-induced arthritis ... Read more

January 21, 2015January 22, 2015

Rheumatoid Arthritis Patients Carry Marker for Personalized Therapeutics

News

Mayo Clinic recently presented a study, at the American College of Rheumatology annual meeting in Boston, showing type 1 interferon as an effective marker to discriminate which treatment rheumatoid arthritis patients should ... Read more

January 5, 2015January 5, 2015

Can-Fite Designs Rheumatoid Arthritis Phase III Trial of Potent Anti-Inflammatory Drug

News

Can-Fite BioPharma Ltd. completed the design of its Phase III study for CF101, an experimental Rheumatoid Arthritis therapy , according to a recent press release. CF101, commercially known as IB-MECA, is a ... Read more

December 16, 2014December 16, 2014

Algorithm Uncovers New Insights into Rheumatoid Arthritis Diagnoses

News

A new study entitled “Validation of the rheumatoid arthritis diagnosis in the Swedish National patient register: a cohort study from Stockholm County” reports than the combination of patients’ data registered ... Read more

December 15, 2014December 15, 2014

Study Finds Increased Insulin Resistance in Rheumatoid Arthritis

News

A new study entitled “Insulin Resistance in Rheumatoid Arthritis: Disease Related Indicators and Associations with the Presence and Progression of Subclinical Atherosclerosis” reports that higher insulin resistance in patients with ... Read more